CA834205A - 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles - Google Patents

1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles

Info

Publication number
CA834205A
CA834205A CA834205A CA834205DA CA834205A CA 834205 A CA834205 A CA 834205A CA 834205 A CA834205 A CA 834205A CA 834205D A CA834205D A CA 834205DA CA 834205 A CA834205 A CA 834205A
Authority
CA
Canada
Prior art keywords
hexahydroazepino
indoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA834205A
Inventor
Jackson B. Hester, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Publication date
Application granted granted Critical
Publication of CA834205A publication Critical patent/CA834205A/en
Expired legal-status Critical Current

Links

CA834205A 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles Expired CA834205A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA834205T

Publications (1)

Publication Number Publication Date
CA834205A true CA834205A (en) 1970-02-10

Family

ID=36311660

Family Applications (1)

Application Number Title Priority Date Filing Date
CA834205A Expired CA834205A (en) 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles

Country Status (1)

Country Link
CA (1) CA834205A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11905295B2 (en) 2021-11-17 2024-02-20 Terran Biosciences Inc. Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11905295B2 (en) 2021-11-17 2024-02-20 Terran Biosciences Inc. Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disorders

Similar Documents

Publication Publication Date Title
CA1021352A (en) Substituted 2-aminomethyl-4,6-dihalophenols
CA1002049A (en) 3,5-dioxopiperazinyl derivatives
CA965104A (en) 3,4,5-trialkylcyclohexanols
CA970373A (en) Pyrazolo (3,4-b) pyridine-5-carboxamides
CA945987A (en) 19-nor-6,6-ethylene-20-spiroxenes
CA834205A (en) 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
CA994768A (en) 3,4-dihydro-1,2,3-oxathiazin-4-ones
CA837636A (en) 1,3-diazacyclo-2,4-butanediones
CA816720A (en) 6-methoxy-1-methyl-9h-pyrido(3,4-b) indoles
AU3151271A (en) Substituted 1, 3-indandiols
CA839720A (en) 2-aryl-1-oxa-3-azaspiro (5,5) undec-2-enes
CA816722A (en) 9-methyl-3-4-dihydroxy-9h-pyrido (3,4-b) indole methochloride
CA827681A (en) 2,3,4,5-tetrahydro-1,4-azepino(4,5-b) indole
AU434258B2 (en) 3, 3a-DIHYDRO-2H, 9H-ISOXAZOLO(3,2-b)(1,3)BENZOXAZIN-9-ONES
CA920138A (en) 3-cycloalkylthio-3-azabicyclo (3.2.2) nonanes
CA833560A (en) 1,2-dihydro-1-hydroxy-2-imino-5-aminopyrimidine derivatives
CA834198A (en) Benzoxazolyl-1,3,4-oxdiazole derivatives
CA838144A (en) 1,2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidine derivatives
CA843941A (en) 9,10-dihydro-anthrol derivatives
CA838136A (en) 1,2-dihydro-1-hydroxy-2-imino-6-lower alkylpyrimidine derivatives
CA838135A (en) 1,2-dihydro-1-hydroxy-2-imino-6-lower alkylpyrimidine derivatives
CA838137A (en) 1,2-dihydro-1-hydroxy-2-imino-5-nitro-pyrimidine derivatives
CA851181A (en) 2,2-ethylenetestosterones
CA854718A (en) 1,2-dihydro-1-hydroxypyrimidines